MedPath

An evaluation of a Mindfulness and Goal Setting Quality of Life Program and Questionnaire

Not Applicable
Completed
Conditions
Well-being
Quality of life
Mental Health - Depression
Mindfulness
Mental Health - Anxiety
Registration Number
ACTRN12620001043921
Lead Sponsor
Prof Peter Drummond
Brief Summary

Mindfulness-based Quality of Life and Well-Being Program (MQW) Brief Results Report As a result of COVID-19, mental health was identi?ed as a growing area in need of attention. In response to this the Mindfulness-based Quality of Life and Well-Being Program (MQW) program was delivered to enable more people to improve their well-being during the pandemic. Two versions of the program were offered to the public, both the full Mindfulness-based Quality of Life and Well-Being Program and the Mindfulness only section of the program with increased time and exercises to practise mindfulness skills. A total of 74 people were randomly allocated to one of the programs and filled out assessments before and after the program. Of this starting group 28 people did not complete at least 4 sessions of the six week program (completion cut off) so these scores were trimmed, leaving a total of 46 participants who completed (MQW full program = 26, Mindfulness only program = 20). To evaluate possible changes in mental health, people filled out a range of mental health and well-being scales including the abbreviated Depression, Anxiety and Stress Scale (DASS-21), the Satisfaction with Life scale (SWL), the Positive and Negative Affect Schedule (PANAS), and the Clinical Quality of Life Scale (CLINQOL) that matched specific program outcomes. In both groups, and across all scales, significant pre-post improvements were reported in the domains of mental health, quality of life and well-being.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
74
Inclusion Criteria

Healthy male or female subjects aged from 18 years old onwards.

Exclusion Criteria

People may not be eligible to participate if they are being treated for a major mental health disorder (for example bipolar disorder or schizophrenia).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath